Disorders of the basal ganglia and their modern management

ISSN： 1470-2118

Source： Clinical Medicine, Vol.33, Iss.4, 1999-07, pp. : 323-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Toxins in Basal Ganglia Disorders: From Animal Models to Therapeutic Strategies

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 69-75

Bentham Science Publishers

Access to resources Recommend Favorite

Aspirin/ephedrine/potassium permanganate abuse: Movement disorders and basal ganglia disorders: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

By van der Stelt M. Di Marzo V.

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 133-150

Elsevier

Access to resources Recommend Favorite

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-11 ,pp. : 777-791

Bentham Science Publishers

Access to resources Recommend Favorite

Simultaneous Bilateral Basal Ganglia Hemorrhage

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 807-815

Bentham Science Publishers

Access to resources Recommend Favorite